MULTIPLE MYELOMA: WHY DOES THE DISEASE ESCAPE FROM PLATEAU PHASE?
- 1 December 1994
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 88 (4) , 667-671
- https://doi.org/10.1111/j.1365-2141.1994.tb05102.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Multiple Myeloma: Expression of Nucleoside Transporters on Malignant Plasma Cells and Their Relationship to Cellular ProliferationLeukemia & Lymphoma, 1994
- Peripheral Blood Lymphocyte Surface Antigen Expression and Prognosis in Myeloma: Australian Leukaemia Study Group StudyLeukemia & Lymphoma, 1994
- Increased expression of natural‐killer‐associated and activation antigens in multiple myelomaAmerican Journal of Hematology, 1992
- Identification of FAP Locus Genes from Chromosome 5q21Science, 1991
- Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction ChemotherapyNew England Journal of Medicine, 1990
- Ras oncogene mutation in multiple myeloma.The Journal of Experimental Medicine, 1989
- SERUM THYMIDINE KINASE AS A MARKER OF DISEASE ACTIVITY IN PATIENTS WITH MULTIPLE MYELOMAAustralian and New Zealand Journal of Medicine, 1989
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989
- Nucleoside transport in acute leukaemia and lymphoma: close relation to proliferative rateBritish Journal of Haematology, 1989
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988